You just read:

Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201

News provided by

Connect Biopharmaceuticals

06 May, 2019, 10:00 BST